Though we did not observe that IL‐3 treatment altered the numbers of microglia and astrocytes in the SNpc compared with the AAV‐hα‐Syn mice (Figure S5, Supporting Information), our data indicated that IL‐3 modulates microglia migration and phagocytosis in the PD mouse model. This evidence concerns the gene IL3 and Parkinson disease.